REQORSA Modulates In Vivo Immune Responses Against Cancers AUSTIN, Texas, Nov. 5, 2024 /PRNewswire/ — Genprex, Inc. (“Genprex” or the “Company”) (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes,…
